ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Multiple preexisting mutant types. While some previous studies have suggested that the majority of CML patients are diagnosed with 0 or 1 preexisting BCR-ABL mutations, some patients do harbor multiple mutants at the start of therapy [2, 6].